<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Engineered on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/engineered/</link>
    <description>Recent content in Engineered on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 24 Feb 2026 06:05:03 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/engineered/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Engineered nanoparticles could deliver better targeted cancer treatment to lymph nodes</title>
      <link>https://cluster-site.onrender.com/posts/engineered-nanoparticles-could-deliver-better-targeted-cancer-treatment-to-lymph-nodes/</link>
      <pubDate>Sat, 21 Feb 2026 22:00:01 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/engineered-nanoparticles-could-deliver-better-targeted-cancer-treatment-to-lymph-nodes/</guid>
      <description>• Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compa</description>
    </item>
  </channel>
</rss>
